3,0
22 jan 2014
Anonieme werknemer
Huidige werknemer
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht
Pluspunten
Best products compared to competition, patient focused, invests heavily in R&D to bring the absolute best products to market for the safest and best possible care in cancer
Minpunten
Very low earning compared to other device/capital companies, continuous changes to comp structure, leadership turnover, realignments of territories and also jobs happen yearly, dis-trust of leadership breeds very low morale among employees